The explanation for our findings was that TRPC1 might promote proliferation via Ca2+ entry and Ca2+- nuclear factor of activated T cells, cytoplasmic 3 (Ca2+-NFATc3) signaling pathways (12, 18), thus resulting in the RCC growth and subsequently affecting tumor size. This evidence concerns the gene NFATC3 and renal cell carcinoma.